{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T04:26:29Z","timestamp":1786767989887,"version":"build-2736575974"},"reference-count":24,"publisher":"Japanese Circulation Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ Rep"],"published-print":{"date-parts":[[2026,8,10]]},"DOI":"10.1253\/circrep.cr-26-0162","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T22:13:18Z","timestamp":1783462398000},"page":"1308-1316","source":"Crossref","is-referenced-by-count":0,"title":["Cumulative Atherogenic Index of Plasma Burden and Risk of Non-Fatal Myocardial Infarction and Ischemic Stroke Beyond Cumulative Low-Density Lipoprotein Cholesterol Burden"],"prefix":"10.1253","volume":"8","author":[{"given":"Naoya","family":"Inoue","sequence":"first","affiliation":[{"name":"Department of Cardiology, Chutoen General Medical Center"},{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruki","family":"Kato","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Chutoen General Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nao","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Chutoen General Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Ohinata","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Chutoen General Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Chutoen General Medical Center"},{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Mishina","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Chutoen General Medical Center"},{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Iwata","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Chutoen General Medical Center"},{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Chutoen General Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Joko","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Chutoen General Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Takayama","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Chutoen General Medical Center"},{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Miyachi","sequence":"additional","affiliation":[{"name":"Department of Surgery, Chutoen General Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Morikawa","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Chutoen General Medical Center"},{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Chong B, Jayabaskaran J, Jauhari SM, Chan SP, Goh R, Kueh MTW, et al. Global burden of cardiovascular diseases: Projections from 2025 to 2050. <i>Eur J Prev Cardiol<\/i> 2025; 32: 1001\u20131015, doi:10.1093\/eurjpc\/zwae281.","DOI":"10.1093\/eurjpc\/zwae281"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, et al. Global burden of cardiovascular diseases and risk factors, 1990\u20132019: Update from the GBD 2019 study. <i>J Am Coll Cardiol<\/i> 2020; 76: 2982\u20133021, doi:10.1016\/j.jacc.2020.11.010.","DOI":"10.1016\/j.jacc.2020.11.010"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Tokgozoglu L, Kay\u0131kcioglu M, Roeters van Lennep J. Sex-specific differences in cardiovascular risk factors and their management. <i>Atherosclerosis<\/i> 2026; 414: 120641, doi:10.1016\/j.atherosclerosis.2026.120641.","DOI":"10.1016\/j.atherosclerosis.2026.120641"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Martin SS, Aday AW, Allen NB, Almarzooq ZI, Anderson CAM, Arora P, et al. 2025 heart disease and stroke statistics: A report of US and global data from the American Heart Association. <i>Circulation<\/i> 2025; 151: e41\u2013e660, doi:10.1161\/CIR.0000000000001303.","DOI":"10.1161\/CIR.0000000000001303"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Ference BA, Ginsberg HN, Graham I, Ray KK, Packard CJ, Bruckert E, et al. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel. <i>Eur Heart J<\/i> 2017; 38: 2459\u20132472, doi:10.1093\/eurheartj\/ehx144.","DOI":"10.1093\/eurheartj\/ehx144"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. <i>Eur Heart J<\/i> 2020; 41: 111\u2013188, doi:10.1093\/eurheartj\/ehz455.","DOI":"10.1093\/eurheartj\/ehz455"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Ginsberg HN, Packard CJ, Chapman MJ, Bor\u00e9n J, Aguilar-Salinas CA, Averna M, et al. Triglyceride-rich lipoproteins and their remnants: Metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies: A consensus statement from the European Atherosclerosis Society. <i>Eur Heart J<\/i> 2021; 42: 4791\u20134806, doi:10.1093\/eurheartj\/ehab551.","DOI":"10.1093\/eurheartj\/ehab551"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Reijnders E, van der Laarse A, Jukema JW, Cobbaert CM. High residual cardiovascular risk after lipid-lowering: Prime time for predictive, preventive, personalized, participatory, and psycho-cognitive medicine. <i>Front Cardiovasc Med<\/i> 2023; 10: 1264319, doi:10.3389\/fcvm.2023.1264319.","DOI":"10.3389\/fcvm.2023.1264319"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Chapman MJ, Packard CJ, Bj\u00f6rnson E, Ginsberg HN, Bor\u00e9n J. Triglyceride-rich lipoproteins, remnants and atherosclerotic cardiovascular disease: What we know and what we need to know. <i>Atherosclerosis<\/i> 2025; 410: 120529, doi:10.1016\/j.atherosclerosis.2025.120529.","DOI":"10.1016\/j.atherosclerosis.2025.120529"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Dobi\u00e1sov\u00e1 M, Frohlich J. The plasma parameter log(TG\/HDL-C) as an atherogenic index: Correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FERHDL). <i>Clin Biochem<\/i> 2001; 34: 583\u2013588, doi:10.1016\/S0009-9120(01)00263-6.","DOI":"10.1016\/S0009-9120(01)00263-6"},{"key":"11","doi-asserted-by":"publisher","unstructured":"11. Onat A, Can G, Kaya H, Hergen\u00e7 G. Atherogenic index of plasma (log10 triglyceride\/high-density lipoprotein-cholesterol) predicts high blood pressure, diabetes, and vascular events. <i>J Clin Lipidol<\/i> 2010; 4: 89\u201398, doi:10.1016\/j.jacl.2010.02.005.","DOI":"10.1016\/j.jacl.2010.02.005"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Rabiee Rad M, Ghasempour Dabaghi G, Darouei B, Amani-Beni R. The association of atherogenic index of plasma with cardiovascular outcomes in patients with coronary artery disease: A systematic review and meta-analysis. <i>Cardiovasc Diabetol<\/i> 2024; 23: 119, doi:10.1186\/s12933-024-02198-y.","DOI":"10.1186\/s12933-024-02198-y"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Ference BA, Braunwald E, Catapano AL. The LDL cumulative exposure hypothesis: Evidence and practical applications. <i>Nat Rev Cardiol<\/i> 2024; 21: 701\u2013716, doi:10.1038\/s41569-024-01039-5.","DOI":"10.1038\/s41569-024-01039-5"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Zhang Y, Pletcher MJ, Vittinghoff E, Clemons AM, Jacobs DR Jr, Allen NB, et al. Association between cumulative low-density lipoprotein cholesterol exposure during young adulthood and middle age and risk of cardiovascular events. <i>JAMA Cardiol<\/i> 2021; 6: 1406\u20131413, doi:10.1001\/jamacardio.2021.3508.","DOI":"10.1001\/jamacardio.2021.3508"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Matsumoto I, Mukaida K, Wada K, Kurozumi M, Namba T, Takagi Y. Long-term exposure to high low-density lipoprotein cholesterol levels and clinical course in secondary prevention after coronary artery disease. <i>Circ Rep<\/i> 2025; 7: 1116\u20131124, doi:10.1253\/circrep.CR-25-0091.","DOI":"10.1253\/circrep.CR-25-0091"},{"key":"16","doi-asserted-by":"publisher","unstructured":"16. Liu Z, Zhang L, Wang L, Li K, Fan F, Jia J, et al. The predictive value of cumulative atherogenic index of plasma (AIP) for cardiovascular outcomes: A prospective community-based cohort study. <i>Cardiovasc Diabetol<\/i> 2024; 23: 264, doi:10.1186\/s12933-024-02350-8.","DOI":"10.1186\/s12933-024-02350-8"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Dobi\u00e1sov\u00e1 M. Atherogenic index of plasma [log(triglycerides\/HDL-cholesterol)]: Theoretical and practical implications. <i>Clin Chem<\/i> 2004; 50: 1113\u20131115, doi:10.1373\/clinchem.2004.033175.","DOI":"10.1373\/clinchem.2004.033175"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Ono Y, Taneda Y, Takeshima T, Iwasaki K, Yasui A. Validity of claims diagnosis codes for cardiovascular diseases in diabetes patients in Japanese administrative database. <i>Clin Epidemiol<\/i> 2020; 12: 367\u2013375, doi:10.2147\/CLEP.S245555.","DOI":"10.2147\/CLEP.S245555"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Koba S, Yokota Y, Satoh N, Ito Y, Tsunoda F, Sakai K, et al. Small dense low-density lipoprotein cholesterol predicts long-term coronary artery disease recurrence in patients without metabolic dyslipidemia. <i>Circ J<\/i> 2026; 90: 999\u20131009, doi:10.1253\/circj.CJ-25-0805.","DOI":"10.1253\/circj.CJ-25-0805"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Nakashima H, Ikeda S, Shinohara K, Matsumoto S, Yoshida D, Nakashima R, et al. Prognostic value of the low-density lipoprotein cholesterol\/high-density lipoprotein cholesterol ratio for cardiovascular events in statin-treated type 2 diabetes with diabetic retinopathy without prior cardiovascular disease. <i>Circ J<\/i> 2026; 90: 492\u2013501, doi:10.1253\/circj.CJ-25-0841.","DOI":"10.1253\/circj.CJ-25-0841"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Wadstr\u00f6m BN, Wulff AB, Pedersen KM, Jensen GB, Nordestgaard BG. Elevated remnant cholesterol increases the risk of peripheral artery disease, myocardial infarction, and ischaemic stroke: A cohort-based study. <i>Eur Heart J<\/i> 2022; 43: 3258\u20133269, doi:10.1093\/eurheartj\/ehab705.","DOI":"10.1093\/eurheartj\/ehab705"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Chen G, Chen Y, Yao Y, Ding L, Wu S, Wu W. High cumulative non-high-density lipoprotein-cholesterol concentration increases the risk of new-onset arterial stiffness: A prospective cohort study. <i>Circ J<\/i> 2025; 89: 629\u2013637, doi:10.1253\/circj.CJ-24-0921.","DOI":"10.1253\/circj.CJ-24-0921"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Endo K, Tanaka M, Sato T, Inyaku M, Nakata K, Kawaharata W, et al. High level of estimated small dense low-density lipoprotein cholesterol as an independent risk factor for the development of ischemic heart disease regardless of low-density lipoprotein cholesterol level: A 10-year cohort study. <i>Circ J<\/i> 2025; 89: 1182\u20131189, doi:10.1253\/circj.CJ-24-0770.","DOI":"10.1253\/circj.CJ-24-0770"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Maruo T, Ike A, Takamiya Y, Matsuoka Y, Shigemoto E, Kato Y, et al. Impact of controlling serum low-density lipoprotein cholesterol and triglycerides on long-term clinical outcomes in diabetic patients who have undergone percutaneous coronary intervention. <i>Circ Rep<\/i> 2024; 6: 573\u2013582, doi:10.1253\/circrep.CR-24-0081.","DOI":"10.1253\/circrep.CR-24-0081"}],"container-title":["Circulation Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/8\/8\/8_CR-26-0162\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T03:29:36Z","timestamp":1786764576000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circrep\/8\/8\/8_CR-26-0162\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1253\/circrep.cr-26-0162","relation":{},"ISSN":["2434-0790"],"issn-type":[{"value":"2434-0790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"article-number":"CR-26-0162"}}